Pharmacists’ Roles in Sexually Transmitted and Blood-Borne Infections
A special issue of Pharmacy (ISSN 2226-4787).
Deadline for manuscript submissions: closed (30 September 2020) | Viewed by 191
Interests: HIV; sexually transmitted and blood-borne infections; point of care testing; pharmacy practice research; professional development of pharmacists
In many parts of the world, the rates of sexually transmitted and blood-borne infections (STBBIs) continue to increase. Populations at higher risk of STBBIs, such as HIV and hepatitis C, are often vulnerable, which creates additional barriers to accessing care. Pharmacists are one of the most accessible health professionals and are taking on expanded roles in public health and disease screening. The availability of new technologies such as point-of-care testing, as well as drugs for prevention and/or treatment of STBBIs, provide further opportunities for pharmacists to provide person-centered services in different settings. This Special Issue will highlight pharmacists’ current roles in providing care for persons living with or at risk of STBBIs, illustrate the value of pharmacists’ contributions, as well as draw attention to future research needed.
We invite you and your colleagues to contribute to this Special Issue on Pharmacists’ Roles in Sexually Transmitted and Blood-Borne Infections. We welcome research submissions on the involvement of pharmacists in screening, prevention, and treatment of STBBIs, including HIV, hepatitis B, hepatitis C, as well as other sexually transmitted infections (bacterial or viral). We also welcome systematic or scoping reviews of the literature on related topics. We look forward to your submissions on how pharmacists can improve care of persons living with or at risk of STBBIs.
Prof. Dr. Christine A. Hughes
Prof. Dr. Debbie V. Kelly
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmacy is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Sexually transmitted and blood-borne infections